Bioscience Asia Takes the Lead: How Can the US Reclaim the Bioscience Crown?
The US are rapidly losing bioscience market share to Asia - The latest data from antibody search engine Cite Ab suggests that the US has continued to lose its share of the biosciences market at an alarming rate over the past year.
Bath/United Kingdom – In February 2014 the search engine released data that suggested growth in China would result in the country soon claiming the lion’s share of global bioscience market, overtaking the United States within the next five to ten years. Today Dr Andrew Chalmers, founder of Cite Ab, says that the latest data suggests not only was this true, but that China could overtake the US earlier than originally thought.
Dr Chalmers said: “Our data clearly shows that there has been a large spike in the number of Chinese research papers using antibodies over the last twelve months. Equally the number of US papers has dropped significantly. This data acts as a fantastic indicator of bioscience research activity.
The Crowning Moment for China
“In 2011 the Royal Society predicted that China would overtake the US in two years, and in 2012 Nature predicted that China would overtake the US by 2014 - both statements that we disagreed with when we issued our report in February 2014. Our assertion, based on Cite Ab data, that it would be later was correct, although the graph below does show that the move in this direction has sped up considerably.”
This data also highlights the increased level of bioscience activity undertaken in India, with consistent growth seen in the country since 2010. The country has now claimed almost 1 per cent of the total global market and looks to still be growing significantly. This will have contributed to the increase in overall Asian market share shown by our data.
Growth on India's Market for Bioproducts
Dr Subhash Gangar, Antibody Development Associate at antibody supplier Novus Biologicals, said: “At Novus we’ve seen a growth in the use of our products in India in recent years, particularly our primary and secondary antibodies, our conjugated primary antibodies and ELISA kits.
“The main research areas our products are used for in India are cancer research, stress response and toxicology research. Institutes such as the top tier universities - BHU, JNU and Annamalai University - and medical organisations such as AIIMS and PGIMER along with a large number of research institutes make up our growing Indian market.”